StarGlory Holdings Company Limited provided earning guidance for the six months ended 30 September 2021. The board of directors of the Company informed the shareholders and potential investors of the Company that based on a preliminary assessment of the unaudited consolidated management accounts of the Group for the six months ended 30 September 2021 (the "Reporting Period") and the information currently available to the Board, the Group is expected to record a loss attributable to owners of the Company within the range of HKD 6.8 million to HKD 9.8 million for the Reporting Period as compared to a profit attributable to owners of the Company of approximately HKD 5.2 million in the corresponding period last year. Such expected loss was mainly due to the combined effect of (i) decrease in other income as no wage subsidies under the Employment Support Scheme launched by the government of the Hong Kong Special Administrative Region (the "HKSAR") and subsidies from the Anti-epidemic Fund from the government of the HKSAR were received and recognized as other income during the Reporting Period while subsidies in the sum of approximately HKD 9.7 million was recorded as other income for the Group's business activities carried out in Hong Kong during the corresponding period last year; and (ii) increase in operating expenses as the Group commenced full operation of its new healthcare business at the beginning of 2021, and has put some financial resources to develop this new segment.